Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M405346200 on June 9, 2004

J. Biol. Chem., Vol. 279, Issue 34, 36093-36102, August 20, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An addition or correction has been published
Right arrow All Versions of this Article:
279/34/36093    most recent
M405346200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tzameli, I.
Right arrow Articles by Flier, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tzameli, I.
Right arrow Articles by Flier, J. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Regulated Production of a Peroxisome Proliferator-activated Receptor-{gamma} Ligand during an Early Phase of Adipocyte Differentiation in 3T3-L1 Adipocytes*

Iphigenia Tzameli{ddagger}, Hui Fang{ddagger}§, Mario Ollero¶||, Hang Shi{ddagger}, Jonathan K. Hamm{ddagger}, Paul Kievit{ddagger}, Anthony N. Hollenberg{ddagger}, and Jeffrey S. Flier{ddagger}**

From the Divisions of {ddagger}Endocrinology and Gastroenterology, Department of Medicine, and the ||Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215

Peroxisome proliferator-activated receptor-{gamma} (PPAR{gamma}) is a nuclear hormone receptor that is critical for adipogenesis and insulin sensitivity. Ligands for PPAR{gamma} include some polyunsaturated fatty acids and prostanoids and the synthetic high affinity antidiabetic agents thiazolidinediones. However, the identity of a biologically relevant endogenous PPAR{gamma} ligand is unknown, and limited insight exists into the factors that may regulate production of endogenous PPAR{gamma} ligands during adipocyte development. To address this question, we created a line of 3T3-L1 preadipocytes that carry a {beta}-galactosidase-based PPAR{gamma} ligand-sensing vector system. In this system, induction of adipogenesis resulted in elevated {beta}-galactosidase activity that signifies activation of PPAR{gamma} via its ligand-binding domain (LBD) and suggests generation and/or accumulation of a ligand moiety. The putative endogenous ligand appeared early in adipogenesis in response to increases in cAMP, accumulated in the medium, and dissipated later in adipogenesis. Organically extracted and high pressure liquid chromatography-fractionated conditioned media from differentiating cells, but not from mature adipocytes, were enriched in this activity. One or more components within the organic extract activated PPAR{gamma} through interaction with its LBD, induced lipid accumulation in 3T3-L1 cells as efficiently as the differentiation mixture, and competed for binding of rosiglitazone to the LBD of PPAR{gamma}. The active species appears to be different from other PPAR{gamma} ligands identified previously. Our findings suggest that a novel biologically relevant PPAR{gamma} ligand is transiently produced in 3T3-L1 cells during adipogenesis.


Received for publication, May 13, 2004

* This work was supported in part by grants from Takeda Chemicals Industries and National Institutes of Health Grant DKR3728082 (to J. S. F.) and by National Institutes of Health Grant 2P30 DK46200-11 (I. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: Pharmacology and Molecular Biology Research Labs., Sankyo Co., Ltd., Tokyo 140-8710, Japan.

** To whom correspondence should be addressed: Beth Israel Deaconess Medical Center, Finard 202, 330 Brookline Ave., Boston, MA 02215. Tel.: 617-667-9050; Fax: 617-667-9054; E-mail: jflier{at}caregroup.harvard.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Schupp, M. I. Lefterova, J. Janke, K. Leitner, A. G. Cristancho, S. E. Mullican, M. Qatanani, N. Szwergold, D. J. Steger, J. C. Curtin, et al.
Retinol saturase promotes adipogenesis and is downregulated in obesity
PNAS, January 27, 2009; 106(4): 1105 - 1110.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
H. E. Xu and Y. Li
Ligand-Dependent and -Independent Regulation of PPAR{gamma} and Orphan Nuclear Receptors
Sci. Signal., December 2, 2008; 1(48): pe52 - pe52.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R. Nielsen, T. A. Pedersen, D. Hagenbeek, P. Moulos, R. Siersbaek, E. Megens, S. Denissov, M. Borgesen, K.-J. Francoijs, S. Mandrup, et al.
Genome-wide profiling of PPAR{gamma}:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis
Genes & Dev., November 1, 2008; 22(21): 2953 - 2967.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. W. Norris, M. F. Hirshman, J. Yao, N. Jessen, N. Musi, L. Chen, W. I. Sivitz, L. J. Goodyear, and C. R. Kahn
Endogenous Peroxisome Proliferator-Activated Receptor-{gamma} Augments Fatty Acid Uptake in Oxidative Muscle
Endocrinology, November 1, 2008; 149(11): 5374 - 5383.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. K. Petersen, L. Madsen, L. M. Pedersen, P. Hallenborg, H. Hagland, K. Viste, S. O. Doskeland, and K. Kristiansen
Cyclic AMP (cAMP)-Mediated Stimulation of Adipocyte Differentiation Requires the Synergistic Action of Epac- and cAMP-Dependent Protein Kinase-Dependent Processes
Mol. Cell. Biol., June 1, 2008; 28(11): 3804 - 3816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Christianson, S. Nicoloro, J. Straubhaar, and M. P. Czech
Stearoyl-CoA Desaturase 2 Is Required for Peroxisome Proliferator-activated Receptor {gamma} Expression and Adipogenesis in Cultured 3T3-L1 Cells
J. Biol. Chem., February 1, 2008; 283(5): 2906 - 2916.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Wang, L. Qiang, and S. R. Farmer
Identification of a Domain within Peroxisome Proliferator-Activated Receptor {gamma} Regulating Expression of a Group of Genes Containing Fibroblast Growth Factor 21 That Are Selectively Repressed by SIRT1 in Adipocytes
Mol. Cell. Biol., January 1, 2008; 28(1): 188 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-L. Chou, L.-M. Chuang, C.-C. Chou, A. H.-J. Wang, J. A. Lawson, G. A. FitzGerald, and Z.-F. Chang
Identification of a Novel Prostaglandin Reductase Reveals the Involvement of Prostaglandin E2 Catabolism in Regulation of Peroxisome Proliferator-activated Receptor {gamma} Activation
J. Biol. Chem., June 22, 2007; 282(25): 18162 - 18172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. A. Spector and A. W. Norris
Action of epoxyeicosatrienoic acids on cellular function
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. Zhang, G. Baker, D. Janus, C. A. Paddon, D. Fuhrer, and M. Ludgate
Biological Effects of Thyrotropin Receptor Activation on Human Orbital Preadipocytes
Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5197 - 5203.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Blumberg, I. Tzameli, I. Astapova, F. S. Lam, J. S. Flier, and A. N. Hollenberg
Complex Role of the Vitamin D Receptor and Its Ligand in Adipogenesis in 3T3-L1 Cells
J. Biol. Chem., April 21, 2006; 281(16): 11205 - 11213.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
W. E. Ackerman IV, X. L. Zhang, B. H. Rovin, and D. A. Kniss
Modulation of Cytokine-Induced Cyclooxygenase 2 Expression by PPARG Ligands Through NF{kappa}B Signal Disruption in Human WISH and Amnion Cells
Biol Reprod, September 1, 2005; 73(3): 527 - 535.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Yu, K. Markan, K. A. Temple, D. Deplewski, M. J. Brady, and R. N. Cohen
The Nuclear Receptor Corepressors NCoR and SMRT Decrease Peroxisome Proliferator-activated Receptor {gamma} Transcriptional Activity and Repress 3T3-L1 Adipogenesis
J. Biol. Chem., April 8, 2005; 280(14): 13600 - 13605.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Mori, H. Sakaue, H. Iguchi, H. Gomi, Y. Okada, Y. Takashima, K. Nakamura, T. Nakamura, T. Yamauchi, N. Kubota, et al.
Role of Kruppel-like Factor 15 (KLF15) in Transcriptional Regulation of Adipogenesis
J. Biol. Chem., April 1, 2005; 280(13): 12867 - 12875.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
D. D. Moore
'No, really, how do they work?'
Genes & Dev., February 15, 2005; 19(4): 413 - 414.
[Full Text] [PDF]


Home page
Genes Dev.Home page
H.-P. Guan, T. Ishizuka, P. C. Chui, M. Lehrke, and M. A. Lazar
Corepressors selectively control the transcriptional activity of PPAR{gamma} in adipocytes
Genes & Dev., February 15, 2005; 19(4): 453 - 461.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement